‎Maharah subsidiary receives financial statements of Saudi Medical System

‎Maharah subsidiary receives financial statements of Saudi Medical System ‎Maharah subsidiary receives financial statements of Saudi Medical System

​‎

Logo ofMaharah Human Resources Co.

Maharah Human Resources Co. announced that its investment arm, Growth Avenue Investment Co. — a wholly owned subsidiary of Maharah holding a 40% stake in its associate, Saudi Medical Systems Co. —received, on Oct. 10, the audited financial statements for 2024.

Advertisement

The subsidiary also received the unaudited preliminary financial statements for Q1 and Q2 of 2025.

In a statement to Tadawul, Maharah disclosed the financial results of Saudi Medical Systems, as shown in the table below:

Saudi Health Systems Financial Results (SAR mln):

Date

Revenue

Net Profit

Year ended Dec. 31, 2024

1,069.67

205.86

Q1 2025*

257.16

51.95

Q2 2025

243.9

39.87

* Unaudited

The company stated that Maharah’s share of the associate’s results will be recognized and included in its consolidated financial statements for Q3 2025 using the equity method, in line with applicable presentation and disclosure requirements.

It added that prior periods may be restated if required under accounting standards, and that the financial impact and any additional details will be disclosed upon the announcement of the Q3 2025 results.

 

Logo ofMaharah Human Resources Co.

Maharah Human Resources Co. announced that its investment arm, Growth Avenue Investment Co. — a wholly owned subsidiary of Maharah holding a 40% stake in its associate, Saudi Medical Systems Co. —received, on Oct. 10, the audited financial statements for 2024.

The subsidiary also received the unaudited preliminary financial statements for Q1 and Q2 of 2025.

In a statement to Tadawul, Maharah disclosed the financial results of Saudi Medical Systems, as shown in the table below:

Saudi Health Systems Financial Results (SAR mln):

Date

Revenue

Net Profit

Year ended Dec. 31, 2024

1,069.67

205.86

Q1 2025*

257.16

51.95

Q2 2025

243.9

39.87

* Unaudited

The company stated that Maharah’s share of the associate’s results will be recognized and included in its consolidated financial statements for Q3 2025 using the equity method, in line with applicable presentation and disclosure requirements.

It added that prior periods may be restated if required under accounting standards, and that the financial impact and any additional details will be disclosed upon the announcement of the Q3 2025 results.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement